Quality of working life and adaptability of returning to work in nurse cancer survivors: a cross-sectional study
Supportive Care in Cancer · 2024-04 · 32 (4)
DOI: 10.1007/s00520-024-08409-2 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 13.03.2024. Verfasst von Wenjing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- The Fifth Affiliated Hospital, Wenzhou Medical University, Lishui, Zhejiang, China.
- The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China. sallyzcm@126.com.
Zitieren
APA
Xu, W., Hu, D., Chen, H., Li, N., Feng, X., Hu, M., Cao, F., Jin, B., & Zhang, C. (2024). Quality of working life and adaptability of returning to work in nurse cancer survivors: a cross-sectional study. Supportive Care in Cancer, 32(4). https://doi.org/10.1007/s00520-024-08409-2
Vancouver
Xu W, Hu D, Chen H, Li N, Feng X, Hu M, et al. Quality of working life and adaptability of returning to work in nurse cancer survivors: a cross-sectional study. Supportive Care in Cancer. 2024;32(4). doi:10.1007/s00520-024-08409-2
BibTeX
@article{Xu2024,
author = {Xu, Wenjing and Hu, Danhong and Chen, Hao and Li, Na and Feng, Xiao and Hu, Miaoye and Cao, Fuxiao and Jin, Bixia and Zhang, Chunmei},
title = {Quality of working life and adaptability of returning to work in nurse cancer survivors: a cross-sectional study},
journal = {Supportive Care in Cancer},
year = {2024},
volume = {32},
number = {4},
doi = {10.1007/s00520-024-08409-2}
}
EUVIMED